Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Kyntra Bio Inc (KYNB) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$3.74M |
|
$-15.20M |
|
$4.11M |
|
$-0.37M |
|
$17.56M |
|
$-13.82M |
|
$-1.31M |
|
$-15.13M |
|
$-15.13M |
|
$-15.13M |
|
$-15.13M |
|
$-15.20M |
|
$-15.13M |
|
$-13.82M |
|
$-13.99M |
|
4.05M |
|
4.05M |
|
$-3.76 |
|
$-3.76 |
|
| Balance Sheet Financials | |
$101.36M |
|
-- |
|
$8.27M |
|
$109.63M |
|
$28.11M |
|
-- |
|
$112.28M |
|
$140.40M |
|
$-30.77M |
|
$-30.77M |
|
$-30.77M |
|
4.05M |
|
| Cash Flow Statement Financials | |
$-13.89M |
|
$3.02M |
|
$-0.01M |
|
$47.87M |
|
$37.00M |
|
$-10.88M |
|
$1.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.61 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-9.84% |
|
-369.66% |
|
-369.66% |
|
-- |
|
-404.82% |
|
-406.58% |
|
$-13.89M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
1.21 |
|
0.74 |
|
121.35 |
|
49.18% |
|
49.18% |
|
-13.80% |
|
49.18% |
|
$-7.60 |
|
$-3.43 |
|
$-3.43 |
|